Theravance Biopharma Inc (TBPH)
9.46
+0.09
(+0.96%)
USD |
NASDAQ |
May 03, 16:00
9.46
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma 1 Year Total Returns (Daily): -14.43% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -14.43% |
May 01, 2024 | -19.71% |
April 30, 2024 | -22.07% |
April 29, 2024 | -16.99% |
April 26, 2024 | -17.76% |
April 25, 2024 | -18.32% |
April 24, 2024 | -18.56% |
April 23, 2024 | -20.24% |
April 22, 2024 | -18.17% |
April 19, 2024 | -19.55% |
April 18, 2024 | -21.10% |
April 17, 2024 | -19.53% |
April 16, 2024 | -18.71% |
April 15, 2024 | -16.78% |
April 12, 2024 | -16.58% |
April 11, 2024 | -21.53% |
April 10, 2024 | -13.51% |
April 09, 2024 | -13.11% |
April 08, 2024 | -13.20% |
April 05, 2024 | -16.05% |
April 04, 2024 | -16.83% |
April 03, 2024 | -17.50% |
April 02, 2024 | -16.13% |
April 01, 2024 | -16.77% |
March 28, 2024 | -15.22% |
Date | Value |
---|---|
March 27, 2024 | -16.50% |
March 26, 2024 | -16.16% |
March 25, 2024 | -16.73% |
March 22, 2024 | -12.29% |
March 21, 2024 | -15.39% |
March 20, 2024 | -13.70% |
March 19, 2024 | -13.66% |
March 18, 2024 | -15.61% |
March 15, 2024 | -18.18% |
March 14, 2024 | -18.85% |
March 13, 2024 | -14.15% |
March 12, 2024 | -16.63% |
March 11, 2024 | -16.14% |
March 08, 2024 | -14.99% |
March 07, 2024 | -13.70% |
March 06, 2024 | -13.89% |
March 05, 2024 | -13.90% |
March 04, 2024 | -9.63% |
March 01, 2024 | -5.98% |
February 29, 2024 | -12.31% |
February 28, 2024 | -12.96% |
February 27, 2024 | -8.24% |
February 26, 2024 | -6.48% |
February 23, 2024 | -12.39% |
February 22, 2024 | -14.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.03%
Minimum
Sep 15 2021
66.86%
Maximum
Jun 09 2020
-13.44%
Average
-15.97%
Median
1 Year Total Returns (Daily) Benchmarks
Corcept Therapeutics Inc | 12.01% |
Nektar Therapeutics | 120.4% |
Vanda Pharmaceuticals Inc | -27.10% |
Fate Therapeutics Inc | -30.91% |
FibroGen Inc | -92.99% |